logo

For the Inventor, By the Inventor

Ostrava, Czechia

Ales Gavenda

This inventor holds 10 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Teva Pharmaceutical Industries Limited, Sicor Inc., Ivax Corporation. Active years: 2010-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ales Gavenda. Retrieved from https://idiyas.com/inventor/ales-gavenda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 62(Granted Patents)


Location History:

  • Lhotka, CZ (2010)
  • Ostrava-Lhotka, CZ (2011 - 2015)
  • Ostrava-Ihotka, CZ (2016)
  • Ostrava, CZ (2011 - 2019)

Company Filing History:

goldMedal4 out of 505 
 
Teva Pharmaceutical Industries Limited
 patents
silverMedal3 out of 26 
 
Sicor Inc.
 patents
bronzeMedal1 out of 5 
 
Ivax Corporation
 patents
4. 1 out of 6 
 
Ivax International Gmbh
 patents
5. 1 out of 54 
 
Teva Pharmaceuticals International Gmbh
 patents

Years Active: 2010-2019

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 10188648 - Solid state forms of selexipag (2019-01-29),
2. 9394266 - Solid state forms of cabazitaxel and processes for preparation thereof (2016-07-19),
3. 9067915 - Sunitinib and salts thereof and their polymorphs (2015-06-30),
4. 8618309 - Sunitinib and salts thereof and their polymorphs (2013-12-31),
5. 8217061 - Polymorphs of sorafenib tosylate and sorafenib hemi-tosylate, and processes for preparation thereof (2012-07-10),
6. 8067423 - Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof (2011-11-29),
7. 8067421 - Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α (2011-11-29),
8. 7977348 - Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α (2011-07-12),
9. 7973045 - Anhydrous form of dasatinib and process for preparation thereof (2011-07-05),
10. 7759481 - Solid state forms of 5-azacytidine and processes for preparation thereof (2010-07-20),

Title: The Innovative Journey of Ales Gavenda

Introduction: Ales Gavenda, a talented inventor hailing from Ostrava-Lhotka, CZ, has made significant contributions to the world of innovation through his creative mind and dedication to progress.

Latest Patents: Ales Gavenda's latest patents showcase his commitment to pushing boundaries in various industries, including technology, engineering, and design.

Career Highlights: Throughout his illustrious career, Ales Gavenda has been recognized for his groundbreaking inventions that have revolutionized the way we approach everyday challenges. His passion for innovation has led to the development of cutting-edge solutions that have improved efficiency and functionality across different sectors.

Collaborations: Ales Gavenda has collaborated with leading experts in the field, sharing his knowledge and expertise to drive forward collaborative projects that have had a lasting impact on the industry. His ability to work effectively in teams has been instrumental in the success of many innovative ventures.

Conclusion: Ales Gavenda's innovative spirit and unwavering dedication to creating solutions for the future continue to inspire generations of inventors and entrepreneurs. His legacy as a pioneering inventor from Ostrava-Lhotka, CZ, is a testament to the power of creativity and perseverance in driving positive change in the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…